Pharmacotherapy and Drug Selection
Pharmacotherapy and drug selection is the clinical-pharmacy area concerned with how medicines are chosen, dosed, monitored, and optimised for a given patient and condition. It links the pharmacology of drug action to the realities of the individual patient, asking not only whether a drug works in general but which drug, at what exposure, is the most appropriate and safest choice in a specific clinical context.
Definition
Pharmacotherapy is the use of medicines to prevent, treat, or manage disease; drug selection is the structured process of choosing among therapeutic options and tailoring exposure to the individual patient on the basis of efficacy, safety, patient factors, and the available evidence.
Scope
The area spans the matching of drugs to patients and indications, individualised dosing including pharmacogenomic considerations, therapeutic drug monitoring of agents with narrow margins, the optimisation of adherence over the course of therapy, and the recognition of drug-drug, drug-disease, and physicochemical interactions. It treats these as reference topics within clinical pharmacy and does not provide prescribing instructions.
Sub-topics
Core questions
- How is a medicine matched to a patient, indication, and clinical goal?
- How can dosing be individualised when patients differ in how they handle and respond to drugs?
- When and how is drug exposure measured to keep therapy within a useful range?
- Why do patients deviate from intended therapy, and how is therapy optimised over time?
- How do drugs interact with one another, with disease, and with one another physicochemically?
Key concepts
- Rational drug use and benefit-risk balancing
- Therapeutic window and exposure-response
- Interindividual variability in drug handling
- Pharmacogenomics and individualised dosing
- Therapeutic drug monitoring
- Medication adherence and optimisation
- Drug-drug and drug-disease interactions
- Potentially inappropriate prescribing
Mechanisms
Drug selection rests on the interplay of pharmacokinetics (how the body absorbs, distributes, metabolises, and eliminates a drug) and pharmacodynamics (how the drug acts on its targets). Patients differ in both, owing to genetics, organ function, age, comorbidity, and concurrent medicines, so a single fixed regimen produces a range of exposures and effects across a population. The area addresses this variability through individualised dosing, measurement of drug exposure where margins are narrow, attention to interactions that alter exposure or effect, and support for adherence so that the intended exposure is actually achieved.
Clinical relevance
The principles in this area underpin how clinicians and pharmacists reason about medicine choice and exposure across the health sciences. As a reference area it explains the conceptual basis of pharmacotherapeutic decision-making; it describes how such decisions are framed and is not itself a source of individualised prescribing, dosing, or treatment advice.
Epidemiology
Medicines are among the most common health-care interventions, and their misalignment with patients is a major source of avoidable harm: adverse drug reactions account for a substantial fraction of hospital admissions, and non-adherence and inappropriate prescribing are widespread, particularly in older people with multimorbidity who take many drugs at once.
Evidence & guidelines
The area draws on clinical pharmacology, pharmacogenomic implementation guidance, explicit prescribing-appropriateness criteria such as STOPP/START, and a large body of trial and observational evidence on individual drug classes. Selection is increasingly framed as evidence-based and, where relevant, genotype-informed, while remaining individualised to the patient.
History
Pharmacotherapy moved over the twentieth century from empirical prescribing toward a quantitative, evidence-based discipline as pharmacokinetics, controlled trials, and later pharmacogenomics matured. The recognition that patients vary systematically in drug handling and response reframed drug selection from choosing a drug for a disease to choosing and tailoring a regimen for a patient.
Related topics
Seminal works
- wilkinson-2005
- roden-2019
- osterberg-2005
Frequently asked questions
- How does drug selection differ from pharmacology?
- Pharmacology describes how drugs act in general; drug selection applies that knowledge to a specific patient and indication, weighing efficacy, safety, patient factors, and evidence to choose and tailor a regimen.
- Why is one standard dose not right for everyone?
- Patients differ in absorption, metabolism, elimination, and response because of genetics, organ function, age, and other drugs, so the same dose can produce very different exposures and effects.